Anna Jamroz-Wiśniewska

5PUBLICATIONS
15CO-AUTHORS
HaematologyGene and molecular therapyRegenerative medicine (incl. stem cells)Medical biotechnology diagnostics (incl. biosensors)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 19, 2025
Adult Hemophagocytic Lymphohistiocytosis (HLH) with Neurological Involvement: Diagnostic Complexities - A Case Report and Literature Review.

Michał J Sekuła, Anna Jamroz-Wiśniewska, Urszula Chyrchel-Paszkiewicz

|Jun 24, 2022
Novel Drugs in a Pipeline for Progressive Multiple Sclerosis.

Klaudia Sapko, Anna Jamroz-Wiśniewska, Konrad Rejdak

|Apr 30, 2021
Modified Rio Score with Platform Therapy Predicts Treatment Success with Fingolimod and Natalizumab in Relapsing-Remitting Multiple Sclerosis Patients.

Anna Jamroz-Wiśniewska, Radosław Zajdel, Agnieszka Słowik

|May 29, 2020
Biomarkers in Multiple Sclerosis: a review of diagnostic and prognostic factors.

Klaudia Sapko, Anna Jamroz-Wiśniewska, Michał Marciniec

|Apr 08, 2020
Cladribine Treatment Improved Homocysteine Metabolism and Increased Total Serum Antioxidant Activity in Secondary Progressive Multiple Sclerosis Patients.

Anna Jamroz-Wiśniewska, Jerzy Bełtowski, Grażyna Wójcicka

Pageof 1

Frequent Collaborators

4 joint publications

Konrad Rejdak

1 joint publications

Klaudia Sapko

1 joint publications

Michał Marciniec

1 joint publications

Marcin Kulczyński